English

Generated Narrative: MedicationStatement mii-exa-onko-medikation-imatinib-atc-version-transition

Profile: MII PR Onkologie Systemische Therapie Medikation version: 2027.0.0-ballot.1

basedOn: CarePlan: identifier = Tumorkonferenz_1; status = active; intent = plan; category = postoperative Tumorkonferenz (Planung der postoperativen Therapie, z. B. zur Frage adjuvante Therapie); created = 2024-01-11

partOf: Procedure Chemotherapie

status: Completed

medication: Imatinib (BCR-ABL Tyrosinkinase-Inhibitor)

subject: Erika Beispiel Female, DoB: 1965-04-12

effective: 2020-12-01 --> 2024-08-30

note:

CML-Protokoll mit Imatinib